Remove 2023 Remove Care at home Remove Medical director Remove Palliate
article thumbnail

Growing Palliative Care a Key Priority for Amedisys in 2024

Hospice News

Want to read more palliative care-focused content like this? Subscribe to Palliative Care News today ! Amedisys (NASDAQ: AMED) is pushing forward on palliative care growth in 2024 through its innovation arm, Contessa. For now, Amedisys shows no signs of slowing down on palliative care. million beneficiaries.

2024 259
article thumbnail

Contessa’s Lessons Learned on Risk-Based Palliative Care

Hospice News

As Contessa Health pioneers a growing value-based palliative care-at-home program, they’ve encountered some learning curves when it comes to operating within a new payment system. Contessa is a subsidiary of Amedisys (NASDAQ: AMED), which the home health and hospice provider acquired in 2021 for $250 million.

article thumbnail

Evaluating Alternate Payment Models in Hospice and Palliative Care

Hospice News

This article is based on a Hospice News discussion with Daniel Schwartz, Chief Strategy Officer at Elara Caring, Devin Woodley, VP of Managed Care Contracting and B2B Sales at VNS Health, Gavin Baumgardner, VP and National Medical Director for Complex and Palliative care at Amedisys, and Anthony Spano, Director of Client Development at Netsmart.